Fever, a common clinical symptom, often indicates an underlying infection or disease process. Despite its prevalence, the management of fever remains a challenge due to its multifaceted nature. This article provides a comprehensive guide to understanding and managing fever in clinical practice.
Fever results from a complex interplay between pyrogens, the immune system, and the hypothalamus. Pyrogens, substances that induce fever, can be either exogenous (from outside the body) or endogenous (from within the body). The hypothalamus, acting as the body's thermostat, responds to pyrogens by raising the body's set-point temperature, triggering fever.
Evaluation of fever involves a thorough history taking and physical examination. Key aspects include the duration and pattern of fever, associated symptoms, recent travel or exposure history, and underlying health conditions. Diagnostic tests, such as complete blood count, blood cultures, and imaging studies, may be necessary based on clinical suspicion.
Management of fever primarily involves treating the underlying cause. Antipyretics, such as acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), are often used for symptomatic relief. However, their use should be judicious, as fever is a natural defense mechanism and its suppression may affect the body's response to infection. Patient education about the nature and course of fever is also crucial.
In certain populations, such as the elderly, infants, and immunocompromised individuals, fever may present atypically or may be absent despite serious infection. In these cases, a high index of suspicion is required, and aggressive diagnostic and therapeutic measures may be warranted.
Understanding and managing fever requires a thorough understanding of its pathophysiology, careful patient evaluation, and appropriate treatment strategies. By considering the individual patient's context and potential underlying causes, clinicians can effectively manage fever and optimize patient outcomes.
1.
A new way to measure suicide risk?
2.
3D virtual staining technology enables non-invasive observation of cancer tissue
3.
Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC
4.
I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.
5.
ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations
1.
Hemophilia B and Gene Therapy: A New Chapter with Etranacogene Dezaparvovec
2.
Driving Impact: Oncology Pharmaceutical Marketing Strategies in the USA
3.
7 Subtle Signs of Leukemia: How to Spot the Symptoms Early
4.
Predicting Incidental Prostate Cancer in BPH Surgery Patients
5.
How Should We Approach Solid Pseudopapillary Neoplasm of the Pancreas with Hepatic Metastases?
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
2.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
3.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
4.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
5.
Navigating the Complexities of Ph Negative ALL - Part IX
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation